Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 196

1.

Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer.

Smith HA, Cronk RJ, Lang JM, McNeel DG.

Cancer Res. 2011 Nov 1;71(21):6785-95. doi: 10.1158/0008-5472.CAN-11-2127. Epub 2011 Aug 31.

PMID:
21880588
[PubMed - indexed for MEDLINE]
Free Article
2.

Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.

Smith HA, McNeel DG.

J Immunother. 2011 Oct;34(8):569-80. doi: 10.1097/CJI.0b013e31822b5b1d.

PMID:
21904219
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

dos Santos NR, Torensma R, de Vries TJ, Schreurs MW, de Bruijn DR, Kater-Baats E, Ruiter DJ, Adema GJ, van Muijen GN, van Kessel AG.

Cancer Res. 2000 Mar 15;60(6):1654-62.

PMID:
10749136
[PubMed - indexed for MEDLINE]
Free Article
4.

Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor.

Dubovsky JA, McNeel DG.

Prostate. 2007 Dec 1;67(16):1781-90.

PMID:
17929270
[PubMed - indexed for MEDLINE]
5.

The SSX family of cancer-testis antigens as target proteins for tumor therapy.

Smith HA, McNeel DG.

Clin Dev Immunol. 2010;2010:150591. doi: 10.1155/2010/150591. Epub 2010 Oct 11. Review.

PMID:
20981248
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Identification of a common HLA-A*0201-restricted epitope among SSX family members by mimicking altered peptide ligands strategy.

He Y, Mao L, Lin Z, Deng Y, Tang Y, Jiang M, Li W, Jia Z, Wang J, Ni B, Wu Y.

Mol Immunol. 2008 May;45(9):2455-64. doi: 10.1016/j.molimm.2008.01.014. Epub 2008 Mar 4.

PMID:
18295890
[PubMed - indexed for MEDLINE]
7.

SSX: a multigene family with several members transcribed in normal testis and human cancer.

Gure AO, Türeci O, Sahin U, Tsang S, Scanlan MJ, Jäger E, Knuth A, Pfreundschuh M, Old LJ, Chen YT.

Int J Cancer. 1997 Sep 17;72(6):965-71.

PMID:
9378559
[PubMed - indexed for MEDLINE]
8.

Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.

Godefroy E, Wang Y, Souleimanian NE, Scotto L, Stevanovic S, Chen YT, Valmori D, Ayyoub M.

Cancer Immunol Immunother. 2007 Aug;56(8):1183-92. Epub 2006 Dec 22.

PMID:
17186289
[PubMed - indexed for MEDLINE]
9.

Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.

Atanackovic D, Luetkens T, Kloth B, Fuchs G, Cao Y, Hildebrandt Y, Meyer S, Bartels K, Reinhard H, Lajmi N, Hegewisch-Becker S, Schilling G, Platzbecker U, Kobbe G, Schroeder T, Bokemeyer C, Kröger N.

Am J Hematol. 2011 Nov;86(11):918-22. doi: 10.1002/ajh.22141. Epub 2011 Sep 2.

PMID:
21898529
[PubMed - indexed for MEDLINE]
10.

SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs.

Taylor BJ, Reiman T, Pittman JA, Keats JJ, de Bruijn DR, Mant MJ, Belch AR, Pilarski LM.

J Immunother. 2005 Nov-Dec;28(6):564-75.

PMID:
16224274
[PubMed - indexed for MEDLINE]
11.

CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells.

Olson BM, McNeel DG.

Cancer Immunol Immunother. 2011 Jun;60(6):781-92. doi: 10.1007/s00262-011-0987-5. Epub 2011 Feb 25.

PMID:
21350948
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.

Wagner C, Neumann F, Kubuschok B, Regitz E, Mischo A, Stevanovic S, Friedrich M, Schmidt W, Rammensee HG, Pfreundschuh M.

Cancer Immun. 2003 Dec 17;3:18.

PMID:
14677925
[PubMed - indexed for MEDLINE]
Free Article
13.

Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.

Ayyoub M, Stevanovic S, Sahin U, Guillaume P, Servis C, Rimoldi D, Valmori D, Romero P, Cerottini JC, Rammensee HG, Pfreundschuh M, Speiser D, Lévy F.

J Immunol. 2002 Feb 15;168(4):1717-22.

PMID:
11823502
[PubMed - indexed for MEDLINE]
Free Article
14.

Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.

Johnson LE, McNeel DG.

Prostate. 2012 May 15;72(7):730-40. doi: 10.1002/pros.21477. Epub 2011 Aug 30.

PMID:
22529020
[PubMed - indexed for MEDLINE]
15.

Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.

Matsueda S, Wang M, Weng J, Li Y, Yin B, Zou J, Li Q, Zhao W, Peng W, Legras X, Loo C, Wang RF, Wang HY.

PLoS One. 2012;7(9):e45756. doi: 10.1371/journal.pone.0045756. Epub 2012 Sep 20.

PMID:
23029225
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Olson BM, Frye TP, Johnson LE, Fong L, Knutson KL, Disis ML, McNeel DG.

Cancer Immunol Immunother. 2010 Jun;59(6):943-53. doi: 10.1007/s00262-010-0820-6. Epub 2010 Feb 6.

PMID:
20140431
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.

Valmori D, Qian F, Ayyoub M, Renner C, Merlo A, Gnjatic S, Stockert E, Driscoll D, Lele S, Old LJ, Odunsi K.

Clin Cancer Res. 2006 Jan 15;12(2):398-404. Erratum in: Clin Cancer Res. 2006 Mar 1;12(5):1656. Gjnatic, Sacha [corrected to Gnjatic, Sacha].

PMID:
16428478
[PubMed - indexed for MEDLINE]
Free Article
18.

CD4+ T cell responses to SSX-4 in melanoma patients.

Ayyoub M, Merlo A, Hesdorffer CS, Rimoldi D, Speiser D, Cerottini JC, Chen YT, Old LJ, Stevanovic S, Valmori D.

J Immunol. 2005 Apr 15;174(8):5092-9.

PMID:
15814740
[PubMed - indexed for MEDLINE]
Free Article
19.

The SSX gene family: characterization of 9 complete genes.

Güre AO, Wei IJ, Old LJ, Chen YT.

Int J Cancer. 2002 Oct 10;101(5):448-53.

PMID:
12216073
[PubMed - indexed for MEDLINE]
20.

The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma.

Ayyoub M, Taub RN, Keohan ML, Hesdorffer M, Metthez G, Memeo L, Mansukhani M, Hibshoosh H, Hesdorffer CS, Valmori D.

Cancer Immun. 2004 Aug 9;4:7.

PMID:
15298487
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk